ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2497

Satisfaction with the Initial Evaluation for a Rheumatologic Complaint Using Telemedicine

Tracy Nguyen-Oghalai1, Michael Lyon2 and Kathy Hunter3, 1RHEUM, VA, Palo Alto, CA, 2Internal medicine, Stanford University, stanford, CA, 3Internal Medicine, VA Palo Alto, Stanford, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Quality improvement and rheumatologic disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Quality Measures and Quality of Care Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Technological advances have facilitated the use of nontraditional forms of health care encounters, such as telemedicine.  The aim of this study was to describe our experience using telemedicine for the evaluation of new patients referred to the Rheumatology Clinic at the Palo Alto VA.

Methods: This is a descriptive study of the initial rheumatologic evaluation using telemedicine conducted as a VA quality assurance project.  Patients  were seen at a community based outpatient clinic by a nurse practitioner (KH) with a Rheumatologist (ML) participating in the encounter via Telelink from our primary site.   Patients completed a satisfaction survey immediately after this initial telemedicine encounter.  All patients had a second visit in person with the same Rheumatologist (ML) at the primary site.  A subsequent telephone survey was conducted by a different provider (TNO) to assess patient satisfaction with both telemedicine and in-person care methods.  Patients were also asked if they had a preference for one or the other care method.

Travel data (mileage) were also collected for both visits.

Results: 37 patients underwent the initial telemedicine evaluation.  All of these had a second in person Rheumatologist visit and completed both questionaires. Ten had  chronic autoimmune conditions such as inflammatory polyarthritis, polymyalgia rheumatica , systemic lupus erythematosus, and ankylosing spondylitis; five had crystal arthropathies.  The remaining 22 patients had non-inflammatory musculoskeletal conditions.  Travel miles were less for all participants for the telemedicine visits relative to the in person visit with the Rheumatologist at the primary site.

Immediately after the telemedicine encounter, all patients gave a 10/10 rating for satisfaction.  During the telephone survey after their in person visit with the Rheumatologist, 30 remained highly satisfied with the telemedicine encounter, 10/10. However, among patients with chronic inflammatory conditions or crystal arthropathies, 66% (10/15) preferred the in person visit.  Among patients with non-inflammatory conditions 41% (9/22) preferred the in person visit with the Rheumatologist.

Preference

In person

telemedicine

Total

Crystal

4

1

5

Chronic autoimmune

6

4

10

No chronic autoimmune

9

13

22

Conclusion: Satisfaction with telemedicine visits was high, but patients with chronic inflammatory disorders or crystalline arthopathies preferred the in-person visits, despite greater travel distances


Disclosure: T. Nguyen-Oghalai, None; M. Lyon, None; K. Hunter, None.

To cite this abstract in AMA style:

Nguyen-Oghalai T, Lyon M, Hunter K. Satisfaction with the Initial Evaluation for a Rheumatologic Complaint Using Telemedicine [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/satisfaction-with-the-initial-evaluation-for-a-rheumatologic-complaint-using-telemedicine/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/satisfaction-with-the-initial-evaluation-for-a-rheumatologic-complaint-using-telemedicine/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology